MAR-PALIPERIDONE

marcan pharmaceuticals inc🇨🇦 Health Canada

Approval Id: 5dd2875eb4430f54
Drug Approval Canada Name: MAR-PALIPERIDONE
Product Name: MAR-PALIPERIDONE
Status: Dormant
Status Date: 2021-11-01
Original Market Date: 2021-06-29
Din: 02511010
Drug Class: Human
Dosage Form: Tablet (Extended-Release)
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 28:16.08.04
Atc Original: N05AX13 PALIPERIDONE
Atc Name: n 05 ax 13
Aig Number: 0152320001
Company Name: marcan pharmaceuticals inc
Company Address: 2 Gurdwara Rd., Suite 112, Ottawa, Ontario, Canada, K2E 1A2

PALIPERIDONE

3 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

5dd2875eb4430f54

Type

Standard